Development
Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 0.53% | 3.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.53% | 3.37% | |||
| Cost of Revenue | 3.30% | 3.01% | |||
| Gross Profit | -7.47% | 4.39% | |||
| SG&A Expenses | -3.83% | 3.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 344.07% | -140.88% | |||
| Total Operating Expenses | 2.85% | 2.00% | |||
| Operating Income | -29.50% | 25.08% | |||
| Income Before Tax | -76.52% | 7.36% | |||
| Income Tax Expenses | -630.70% | 77.13% | |||
| Earnings from Continuing Operations | -60.05% | -1.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -68.57% | 180.00% | |||
| Net Income | -60.08% | -0.90% | |||
| EBIT | -29.50% | 25.08% | |||
| EBITDA | -13.30% | 12.64% | |||
| EPS Basic | -62.50% | 0.00% | |||
| Normalized Basic EPS | -77.96% | 8.65% | |||
| EPS Diluted | -62.50% | 0.00% | |||
| Normalized Diluted EPS | -77.96% | 8.65% | |||
| Average Basic Shares Outstanding | 6.44% | -0.90% | |||
| Average Diluted Shares Outstanding | 6.44% | -0.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | -- | |||